Chemoprevention of Oral Premalignant Lesions
NCT00036283 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 42
Last updated 2008-09-29
Summary
Reduction in size and number of oral premalignant lesions
Conditions
- Precancerous Conditions
Interventions
- DRUG
-
Celecoxib
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Pfizer CT.gov Call Center · Pfizer
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2000-11-30
- Completion
- 2004-04-30
Countries
- United States
Study Locations
More Related Trials
-
Bowman-Birk Inhibitor Concentrate in Preventing Cancer in Patients With Oral Leukoplakia
NCT00330382 ·Status: COMPLETED ·Phase: PHASE2
-
Molecular Mechanisms of the Development of Precancerous and Cancerous Lesions of the Oral Cavity
NCT03026361 ·Status: COMPLETED
-
A Randomized Study of Sulindac in Oral Premalignant Lesions
NCT00299195 ·Status: COMPLETED ·Phase: NA
-
SWOG-9507, Fenretinide in Treating Patients With Neoplasia of the Mouth
NCT00003223 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy of SNX-1012 in the Treatment of Oral Mucositis
NCT00385515 ·Status: COMPLETED ·Phase: PHASE2
-
Chemical and Genetic Effects of the Experimental Anti-Cancer Drugs in Cheek Cells in Cancer Patients
NCT00055380 ·Status: COMPLETED ·Phase: PHASE1
-
Tobacco and Alcohol Influence on Oncogenic Drivers and Somatic Evolution in the Oral Mucosa
NCT06094829 ·Status: COMPLETED
-
In Vivo Confocal Imaging of Oral Mucosa
NCT00502125 ·Status: COMPLETED
-
Pioglitazone for Oral Premalignant Lesions
NCT00951379 ·Status: TERMINATED ·Phase: PHASE2
-
The Oral Microbiome as a Prognostic Tool in Oral Malignant and Premalignant Lesions and in Medication Related Osteonecrosis of the Jaw
NCT03418454 ·Status: UNKNOWN
-
Oral Microbioma and Oral Malignant Disease
NCT05766150 ·Status: UNKNOWN
-
Innovative Approach to Triage Oral Precancer
NCT03202810 ·Status: UNKNOWN
-
Safety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Chemoradiation for the Treatment of Oral Cancers
NCT03515538 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Study of SBG vs Placebo in Head and Neck Cancer Patients Undergoing Radiation Therapy
NCT00790322 ·Status: COMPLETED ·Phase: PHASE3
-
Chemoprevention Study of Oral Cavity Squamous Cell Carcinoma
NCT00201279 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of RK0202 in Oral Mucositis
NCT00230191 ·Status: COMPLETED ·Phase: PHASE2
-
Cobiprostone for the Prevention of Oral Mucositis in Subjects With Head and Neck Cancer Receiving Concurrent Radiation and Chemotherapy
NCT02542215 ·Status: TERMINATED ·Phase: PHASE2
-
Clinical and Molecular Features of Oral Premalignancy and Oral Cancer
NCT06550050 ·Status: RECRUITING
-
Rosiglitazone Maleate in Treating Patients With Oral Leukoplakia
NCT00369174 ·Status: COMPLETED ·Phase: PHASE2
-
RRx-001 for Reducing Oral Mucositis in Patients Receiving Chemotherapy and Radiation for Head and Neck Cancer
NCT05966194 ·Status: RECRUITING ·Phase: PHASE2
-
Efficacy, Safety and Tolerability of AG013 in Oral Mucositis Compared to Placebo When Administered Three Times Per Day
NCT03234465 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy of Topical Coenzyme Q10 and Curcumin for Oral Leukoplakia Treatment
NCT07331935 ·Status: RECRUITING ·Phase: NA
-
Impact of the Oral Microbiota on Relapse in HNSCC Patients
NCT06807034 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Infectious Aetiology of Potentially Malignant Disorders and Squamous Cell Carcinomas of the Oral Cavity
NCT01636544 ·Status: COMPLETED ·Phase: NA
-
Freeze-Dried Black Raspberries in Preventing Oral Cancer Recurrence in High At-Risk Appalachian Patients Oral Cancer Survivors
NCT01504932 ·Status: COMPLETED ·Phase: NA